FTC's Norman PHO Advisory Opinion - New Clinical Integration Guidance, Same Antitrust Analysis

by Baker Donelson

The Federal Trade Commission (FTC) provided its first guidance for clinically integrated networks since passage of the Affordable Care Act (ACA) and the joint FTC/DOJ Accountable Care Organization (ACO) Antitrust Policy Statement in a February 13 advisory opinion [PDF]. The FTC’s favorable letter was issued in response to a proposal by the Norman Physician Hospital Organization (PHO) to form a clinically integrated health care network. While the advisory opinion provides new guidance regarding the details of a clinical integration program sufficient to pass antitrust muster in the post-ACO world, it reaffirms the FTC’s overall antitrust analysis of clinically integrated provider networks.

The Norman PHO, which was originally founded in 1994 and includes 280 physicians of the Norman Physician Association and the hospitals and clinics of the Normal Regional Health System, proposed to form a network to offer clinically integrated services as a vehicle for improving quality of care, reducing costs, and increasing patient satisfaction, and in order to implement those services, to jointly negotiate the payer contracts for its physicians’ services. Previously, the PHO utilized a “messenger model” to contract with payors.

Specifically, under the proposed clinical integration program, the PHO’s participating physicians are required to actively participate in a variety of collaborative clinical activities, develop and follow clinical practice guidelines, utilize physician performance measures, conduct peer review and corrective actions, design and implement quality improvement initiatives, and significantly, adopt and use an electronic medical information and records system (including e-prescribing and an electronic clinical decisions support system). The clinical integration program would rely on a new organizational structure including several new committees and a new Participating Practitioner Agreement that places substantial emphasis on physician participation, commitment, and investment in the program. Similarly, the program requires time and financial commitment by participating physicians, including “withholds” from payer contracts to finance the clinical integration program.

As a result of this clinical integration program, the FTC concluded that, although joint contracting by physicians generally constitutes price-fixing, which is a a per se violation of the antitrust laws, the Norman PHO qualified for rule-of-reason analysis. Importantly, the advisory opinion stated that “Norman PHO’s proposed joint contracting appears to be subordinate to the network’s effort to improve efficiency and quality through the clinical integration of its participating physicians,” that is, the joint contracting is an “ancillary” (i.e., reasonably necessary) component of the clinical integration initiative. The FTC further stated that the PHO’s proposed activities appeared “unlikely to unreasonably restrain trade” based on a number of factors (although the advisory opinion noted that staff did not conduct a formal market analysis). First, and most significant, the PHO will be non-exclusive   allowing payers to contract with individual member physicians independently from the PHO, thus there will be a sufficient number of contracting alternatives left for payers who do not want to contract through the PHO. In addition, the joint contracting would involve only physician services, and inpatient and outpatient hospital services would be excluded (because the Norman Regional Health System is the only provider of such services in the network). Finally, the PHO’s proposal contains affirmative safeguards against anticompetitive conduct such as refusals to deal or sharing competitors’ competitively sensitive information.

As a result, the FTC concluded that, while the PHO could exercise market power, the proposal appeared “likely, on balance, to be procompetitive or competitively neutral,” because it “offers the potential to create a high degree of interdependence and cooperation among its participating physicians and to generate significant efficiencies in the provision of physician services.”

In sum, the advisory opinion provides details regarding the elements of a clinical integration program, including those implemented by an ACO, that the FTC will find sufficient to allow joint contracting by otherwise competing providers who are not fully merged into a single entity under the antitrust laws. The FTC also reiterated the factors it will consider important in the antitrust analysis of such networks. In some circumstances, providers may find that fully merging allows more flexibility and certainty in payor contracting and other operational activities; in others, fully integrating will not be feasible and forming a clinically integrated network is the best option. Providers must weigh the benefits and costs of clinically integrated networks and similar joint ventures against those presented by fully merging, including hospital acquisition and employment of physicians.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Baker Donelson | Attorney Advertising

Written by:

Baker Donelson

Baker Donelson on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.